Stay updated on VK2809 Efficacy in NASH Clinical Trial

Sign up to get notified when there's something new on the VK2809 Efficacy in NASH Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the VK2809 Efficacy in NASH Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer now identifies the release as v3.8.1 instead of v3.8.0.
    Difference
    0.0%
    Check dated 2026-11-18T01:39:37.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The VK2809 Phase 2B study record for NASH is available, with its design, eligibility criteria, outcomes, participating locations, and completed status displayed in place of the access-error page.
    Difference
    75%
    Check dated 2026-11-10T22:46:43.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-03T22:55:25.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    A banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence,” and the site revision changes from v3.7.1 to v3.7.2. The study record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-20T22:04:46.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The site footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-06T22:09:50.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of study details, replacing the content with an error message and signaling an access issue rather than new information.
    Difference
    17%
    Check dated 2026-09-23T00:22:31.000Z thumbnail image

Stay in the know with updates to VK2809 Efficacy in NASH Clinical Trial

Enter your email address, and we'll notify you when there's something new on the VK2809 Efficacy in NASH Clinical Trial page.